Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Terms of Use
Privacy Policy
Sitemap
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Breast Cancer
•
Medical Oncology
•
Breast Cancer, Non-metastatic
How do you approach treating alopecia secondary to endocrine therapy?
Other causes have been ruled out. Any role for spironolactone?
Related Questions
Is there any adjunct therapy to help with tamoxifen-induced leg cramps?
How would you approach adjuvant endocrine therapy in a previously premenopausal patient with ipsilateral recurrence while on OS and AI, 2 years after receiving ddAC-T chemotherapy and adjuvant radiation?
Is there a role for adjuvant capecitabine in sequence with abemaciclib for high risk HR+ breast cancer with residual disease?
Would you offer adjuvant chemotherapy to a post menopausal woman with T1-T3 primary tumor with 4 positive axillary LNs and OncotypeDX score less than 15?
Would you treat a Stage I ER/PR positive HER2 negative breast cancer differently if it is associated with Lynch syndrome?
Does abemaciclib have same magnitude of benefit in patients with lobular breast cancer in adjuvant and metastatic setting compared to ductal breast cancer?
Would you give chemotherapy to a post menopausal woman with ER/PR positive HER2 negative breast cancer, T2N1 with 3+ lymph nodes, Ki-67 30% and OncoType RS of 10?
What neoadjuvant chemo regimen would you recommend for a patient with LN positive TNBC and a history of CVA, neuropathy, and risk factors for heart disease but normal echo?
Would you offer adjuvant abemaciclib plus endocrine therapy for favorable histology ER+/PR+/HER2-negative tumors such as pure tubular, mucinous, cribriform, or papillary that otherwise meet MonarchE trial criteria?
What neoadjuvant regimen would you give a patient with multicentric IDC consisting of TNBC and concurrent ER/PR- HER2+ breast cancer with ER/PR- HER2+ axillary LN mets?
